Drugmaker Sues F.D.A. Over Right to Discuss Off-Label Uses

Friday, May 8, 2015 - 06:20 in Psychology & Sociology

Amarin Pharma says it has a constitutional right to share information on unapproved uses of its products, a practice the government frowns on.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net